4//SEC Filing
Valamehr Bahram 4
Accession 0000950170-24-088775
CIK 0001434316other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 6:05 PM ET
Size
5.4 KB
Accession
0000950170-24-088775
Insider Transaction Report
Form 4
Valamehr Bahram
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-07-29+200,000→ 358,069 total
Footnotes (1)
- [F1]These shares were granted pursuant to a restricted stock unit award. 100,000 of the units are subject to time-based vesting and 100,000 of the units are subject to performance-based vesting. 25,000 time-based units will vest on August 1, 2025 and 75,000 time-based units will vest on August 1, 2026, so long as the reporting person continues to serve as an employee of the issuer through each vesting date. Subject to the achievement of specified late-stage clinical and regulatory milestones of the issuer on or before July 29, 2028, half of the performance-based units will vest one year after the achievement of two of three of the milestones, and the remaining 50,000 of the performance-based units will vest on the date one year after the achievement of all three of the milestones, in each case subject to the grantee's continued employment with the issuer through each such vesting date.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001748177
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 6:05 PM ET
- Size
- 5.4 KB